微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.75% | -4.84% | -76.27% | 26/129 | 1.05% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 11.59% | 13.07% | 23.69% | 17/129 | 2.96% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 9.37% | 9.46% | 59.08% | 20/129 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 5.89% | 14.59% | 103.81% | 26/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2.89% | 22.46% | -71.8% | 29/129 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 10.25% | -14.37% | 19.74% | 29/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 8.56% | -23.43% | 66.54% | 38/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 5.14% | -28.51% | 117.8% | 43/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 2.36% | -33.33% | -80.28% | 52/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 11.97% | -6.92% | 7.07% | 58/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 11.18% | 5.08% | 55.49% | 49/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 7.19% | 9.1% | 103.11% | 52/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 3.54% | -1.67% | -72.47% | 42/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 12.86% | -5.93% | 20.86% | 67/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 10.64% | 2.6% | 61.46% | 55/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 6.59% | 1.38% | 83.06% | 60/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 3.6% | 4.35% | -73.66% | 44/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 13.67% | 11.77% | 31.82% | 73/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 10.37% | 11.15% | 59.54% | 51/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 6.5% | 7.62% | 88.41% | 63/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 3.45% | 11.29% | -71.79% | 24/129 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 12.23% | 20.61% | 31.08% | 67/129 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 9.33% | 18.85% | 54.47% | 32/129 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 6.04% | 18.66% | 94.84% | 35/129 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 3.1% | 23.02% | -69.43% | 18/129 | 2.72% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 10.14% | 30% | 29.17% | 70/129 | 12.98% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 7.85% | 22.66% | 54.22% | 32/129 | 7.16% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 5.09% | 20.33% | 101.98% | 26/129 | 3.21% | 明德生物 | 14.54% | 行业排名> |
| 2018-03-31 | 2.52% | 19.43% | -67.69% | 23/129 | 2.62% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 7.8% | -11.16% | 21.88% | 71/129 | 13.82% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 6.4% | 12.08% | 51.3% | 30/129 | 9.43% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 4.23% | 0% | 100.47% | 37/129 | 5.9% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.11% | 22.67% | -75.97% | 21/129 | 2.66% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 8.78% | 29.5% | 53.77% | 54/129 | 16.21% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 5.71% | 8.56% | 34.99% | 26/129 | 8.69% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 4.23% | 25.89% | 145.93% | 28/129 | 6.26% | 明德生物 | 23.29% | 行业排名> |
| 2016-03-31 | 1.72% | 13.16% | -74.63% | 20/129 | 2.14% | 健帆生物 | 7.75% | 行业排名> |
| 2015-12-31 | 6.78% | 10.97% | 28.9% | 50/129 | 15.95% | 大博医疗 | 55.39% | 行业排名> |
| 2015-09-30 | 5.26% | 11.91% | 56.55% | 24/129 | 7.79% | 鱼跃医疗 | 17.33% | 行业排名> |
| 2015-06-30 | 3.36% | 2.75% | 121.05% | 36/129 | 7.77% | 明德生物 | 29.93% | 行业排名> |
| 2015-03-31 | 1.52% | 4.11% | -75.12% | 25/129 | 3.2% | 中源协和 | 14.44% | 行业排名> |